Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Michael Harsh is Director at Endra Life Sciences. OQRO lists 1 transaction filed with the SEC under this name, the latest on Jan 24, 2026, each linked to the official Form 4.
Director
Disclosures on record
1
Companies involved
1
As of the latest filing on , Michael Harsh reported holding 65,710 shares of Endra Life Sciences (NDRA), worth about $290K at the last close of $4 (Nov 13, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Endra Life Sciences NDRA | 65,710 | 66K direct | $4 | $290K | Jan 21, 2026 |
Is this Michael Harsh’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Michael Harsh bought shares on the open market in 2019, and has not bought since 2019.
Michael Harsh reported 4 open-market purchases and 0 sales since 2019; purchases in 2019.
| Year | Bought | Sold |
|---|---|---|
| 2019 | $11K4×4 trades | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Jan 21, 202660Kdisclosed Jan 24
DetailsOfficial recordMichael Harsh reported 4 open-market purchases and 0 sales here, 2019.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
On the latest SEC Form 4, dated Jan 21, 2026, Michael Harsh reported holding 65,710 shares of Endra Life Sciences (NDRA). At the last close of $4 on Nov 13, 2026, that is about $290K. This is the stake disclosed in filings, not a net worth.
Michael Harsh bought shares on the open market in 2019, and has not bought since 2019.
In SEC filings since 2019: the latest open-market purchase is from 2019; no open-market sale is on record.
Endra Life Sciences (NDRA), from 2019 to 2019: 4 purchases and 0 sales.
